About Shannon

Shannon Cope, MSc, is a Vice President with PRECISIONheor. Shannon has over ten years of experience consulting for biopharmaceutical industry regarding evidence synthesis and economic evaluations to assess the value of new interventions.

Shannon leads and manages evidence synthesis projects involving systematic reviews, (network) meta-analyses, population-adjusted indirect comparisons (simulated treatment comparisons and matching-adjusted indirect comparisons), and economic models. She has technical experience including synthesis methods related to aggregate and individual patient level data, time-to-event outcomes and repeated measures, and integration of evidence from expert elicitation, integration of single-arm studies. She has developed cost-effectiveness models incorporating flexible parametric models, and been involved with HTA reimbursement dossiers in the UK, Scotland, Canada, Sweden, Netherlands, and Australia. She has provided methods-based trainings and workshops, and published more than twenty articles in scientific peer-reviewed journals.

She has extensive experience in oncology, as well as several therapeutic areas including CAR-T therapy, cardiology, chronic obstructive pulmonary disease, asthma, and epilepsy. Prior to joining PRECISIONheor, Shannon was a Director at Mapi Group. She holds an MSc in Health Administration from the University of Toronto, Canada, and Bachelor of Health Sciences from McMaster University in Hamilton, Canada.

EDUCATION
MSc, University of Toronto, Canada